Implications of Pharmacogenomics for Anesthesia Providers


Pharmacogenomics considerations have the potential to develop therapeutic outcomes and individualise drug therapy while avoiding toxic effects and treatment failure by increasing the knowledge base of anaesthesia providers. However, because pharmacogenomics may not explain all inconsistencies in drug response, it must be used in conjunction with traditional anaesthesia considerations.

  • Drug Therapy
  • Drug Variability
  • Pharmacogenetics



 


    Related Conference of Implications of Pharmacogenomics for Anesthesia Providers

    November 22-23, 2024

    5th Global Summit on Public Health

    Paris, France
    November 25-26, 2024

    10th World Holistic Nursing Conference

    Bali, Indonesia
    January 27-28, 2025

    10th World Congress on Public Health and Nutrition

    Bangkok, Thailand
    February 24-25, 2025

    21st Global Congress on Healthcare and Technologies

    Madrid, Spain
    March 17-18, 2025

    5th International conference on Healthcare Summit

    Singapore City, Singapore
    March 27-28, 2025

    7th International Conference on Digital Health

    London, UK
    April 07-08, 2025

    7th World Summit on Women's Health and Cancer Awareness

    Vancouver, Canada
    April 24-25, 2025

    4th International Congress on Global Healthcare

    Vienna, Austria
    May 14-15, 2025

    7th World Conference on Vaccine and Immunology

    Barcelona, Spain
    May 22-23, 2025

    International Congress on Primary Health and Safety

    Toronto, Canada
    July 23-24, 2025

    30th International Conference on Skincare and Cosmetology

    Amsterdam, Netherlands
    July 24-25, 2025

    36th European Heart and Heart Failure Congress

    Paris, France
    September 22-23, 2025

    21st Global Biomarkers and Clinical Research Summit

    Paris, France

    Implications of Pharmacogenomics for Anesthesia Providers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in